The results obtained in the cellular models also have a therapeutic relevance for treatment of schizophrenia since they indicate that the NTR1 protomer in the D2R–NTR1 heteroreceptor complex of the ventral striatum can reduce D2R protomer signaling over the Gi/o–AC–CREB pathway. This evidence concerns the gene NTSR1 and schizophrenia.